Cic edizioni internazionali
Functional Neurology

Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey

Original Article, 37 - 43
doi: 10.11138/FNeur/2018.33.1.037
Tag this article
Abstract
Full text PDF
The present paper provides practical guidance on the management of adult spasticity with OnabotulinumtoxinA.
Advisory Board members reviewed the available evidence and discussed their personal experiences in order to address the unmet needs in the management of spasticity with botulinum toxin type A identified by the recent Italian Real-Life Post-Stroke Spasticity Survey.
Stroke patients should be referred to spasticity services that have adequate facilities and multidisciplinary teams with the necessary training, competence and expertise. The current literature shows a strong correlation between the development of
post-stroke spasticity and the degree of central sensorimotor system destruction/disorganization. Use of tools such as the Poststroke Checklist may help clinicians in the long-term follow-up of stroke patients.
The maximum dose of onabotulinumtoxinA — according to the current literature this ranges from 300U to 400U for upper limb and from 500U to 600U for lower limb aggregate postures — should be re-considered. In addition, there is a need for future consensus (also based on pharmacoeconomic considerations) on consistent clinical care models for the management of patients with post-stroke spasticity.

Vol. XXXIII (No. 1) 2018 January/March

  1. Mechanical thrombectomy for acute ischemic stroke: the therapeutic window is larger but still “time is brain»
    Zivelonghi C., Tamburin S.
    doi: 10.11138/FNeur/2018.33.1.005
  2. Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal
    Ferrari A., Manca M., Tugnoli V., Alberto L.
    doi: 10.11138/FNeur/2018.33.1.007
  3. Multicentre registry of brain-injured patients with disorder of consciousness: rationale and preliminary data
    Pascarella A., Fiorenza S., Masotta O., Tibollo V., Vella D., Nardone A. M., Rossi M., Volanti P., Madonia F., Castronovo G., De Cicco D., Guarnaschelli C., Achilli M.P., Chiapparino C., Angelillo M.T., Tommasi M.A., Pisano F., Grioni G., Vezzadini G., Ferriero G., Salvaderi S., Bellazzi R., Estraneo A.
    doi: 10.11138/FNeur/2018.33.1.019
  4. Apathy in Parkinson’s disease: differences between caregiver’s report and self-evaluation
    Valentino V., Iavarone A., Amboni M., Moschiano F., Picillo M., Petretta V., Cicarelli G.
    doi: 10.11138/FNeur/2018.33.1.031
  5. Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey
    Sandrini G., Baricich A., Cisari C., Paolucci S., Smania N., Picelli A.
    doi: 10.11138/FNeur/2018.33.1.037
  6. A role for accelerometry in the differential diagnosis of tremor syndromes
    Bove F., Di Lazzaro G., Mulas D., Cocciolillo F., Di Giuda D., Bentivoglio A.R.
    doi: 10.11138/FNeur/2018.33.1.045
  7. Effectiveness of a digital platform for sharing knowledge on headache management: a two-year experience
    Raieli V., Correnti E., Sandullo A., Romano M., Marchese F., Loiacono C., Brighina F.
    doi: 10.11138/FNeur/2018.33.1.051
  8. If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences
    Rossi P., Little P., De La Torre E.R., Palmaro A.
    doi: 10.11138/FNeur/2018.33.1.057
Last Viewed articles: la lista degli ultimi x visitati.
  1. Management of spasticity with onabotulinumtoxinA: practical guidance based on the italian real-life post-stroke spasticity survey
    Sandrini G., Baricich A., Cisari C., Paolucci S., Smania N., Picelli A.
    doi: 10.11138/FNeur/2018.33.1.037
credits